Victoria J Bartlett

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk

D. Gaudet, J. Tardif, C. Ballantyne, 2022, European heart journal.

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

D. Gaudet, J. Witztum, E. Hurh, 2020, European heart journal.

Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors.

S. Levy, M. Grier, A. Verma, 2007, Bioorganic & medicinal chemistry letters.

Small Molecule Inhibitors of LcrF, a Yersinia pseudotuberculosis Transcription Factor, Attenuate Virulence and Limit Infection in a Murine Pneumonia Model

J. Mecsas, S. Levy, A. Verma, 2010, Infection and Immunity.

N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents.

S. Levy, M. Grier, A. Verma, 2009, Journal of medicinal chemistry.

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study

E. Hurh, M. Foss-Freitas, E. Karwatowska-Prokopczuk, 2021, Lipids in health and disease.

A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer

F. Sarkar, H. Banerjee, M. Verma, 2022, Journal of analytical oncology.